Literature DB >> 1991732

Defective transcription of the right end of bacteriophage T7 DNA during an abortive infection of F plasmid-containing Escherichia coli.

P J Beck1, I J Molineux.   

Abstract

Transcription of T7 and mutant T3 DNA during infections of F plasmid-containing cells has been analyzed by using Southern hybridization. A transcriptional defect is apparent in these abortively infected cells that is most severe in the class III region of the phage genome. In particular, RNAs that are initiated from the gene 13 promoter are not elongated to give full-length molecules. It is suggested that the transcription defect results from positive supercoiling of the template DNA and that torsional constraints may even prevent the complete entry of the phage genome into an abortively infected cell.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1991732      PMCID: PMC207210          DOI: 10.1128/jb.173.3.947-954.1991

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  42 in total

1.  A link between streptomycin and rifampicin mutation.

Authors:  S L Chakrabarti; L Gorini
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  T7 protein synthesis in F' episome-containing cells: assignment of specific proteins to three translational groups.

Authors:  T G Morrison; D D Blumberg; M H Malamy
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

Review 3.  Bacteriophage T7.

Authors:  F W Studier
Journal:  Science       Date:  1972-04-28       Impact factor: 47.728

4.  The genetics and physiology of bacteriophage T7.

Authors:  F W Studier
Journal:  Virology       Date:  1969-11       Impact factor: 3.616

5.  Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA.

Authors:  W B Wood
Journal:  J Mol Biol       Date:  1966-03       Impact factor: 5.469

6.  T7 translational control mechanisms and their inhibiton by F factors.

Authors:  T G Morrison; M H Malamy
Journal:  Nat New Biol       Date:  1971-05-12

7.  Permeability lesions in male Escherichia coli infected with bacteriophage T7.

Authors:  J R Britton; R Haselkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

8.  Effect of nalidixic acid on the growth of deoxyribonucleic acid bacteriophages.

Authors:  J P Baird; G J Bourguignon; R Sternglanz
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

9.  Growth of bacteriophages MS2 and T7 on streptomycin-resistant mutants of Escherichia coli.

Authors:  S Chakrabarti; L Gorini
Journal:  J Bacteriol       Date:  1975-02       Impact factor: 3.490

10.  Evidence for the presence of nontranslated T7 late mRNA in infected F'(PIF+) episome-containing cells.

Authors:  D D Blumberg; M H Malamy
Journal:  J Virol       Date:  1974-02       Impact factor: 5.103

View more
  5 in total

1.  Expression of gene 1.2 and gene 10 of bacteriophage T7 is lethal to F plasmid-containing Escherichia coli.

Authors:  C K Schmitt; I J Molineux
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

2.  Expression, regulation, and mode of action of the AbiG abortive infection system of lactococcus lactis subsp. cremoris UC653

Authors: 
Journal:  Appl Environ Microbiol       Date:  1999-01       Impact factor: 4.792

3.  Incomplete entry of bacteriophage T7 DNA into F plasmid-containing Escherichia coli.

Authors:  L R García; I J Molineux
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

4.  Genes 1.2 and 10 of bacteriophages T3 and T7 determine the permeability lesions observed in infected cells of Escherichia coli expressing the F plasmid gene pifA.

Authors:  C K Schmitt; P Kemp; I J Molineux
Journal:  J Bacteriol       Date:  1991-10       Impact factor: 3.490

5.  Rate of translocation of bacteriophage T7 DNA across the membranes of Escherichia coli.

Authors:  L R García; I J Molineux
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.